Member Info for LovableLumax

FUD? Last year I called a raise it you called it FUD and looked what happened you threw your toys out of some poor kid’s pram and called it mates rates. Haha, what a thicko.

You then pumped and sold out, not once but twice! Low life.

Yes I am long on Avacta that’s trying to create kinder cancer therapies. Silly me.

Anyway, I’ll leave it for now. If I’m wrong and they don’t try and at the latest in April I’ll happily apologise and say well done.

phevs the creep who looks like he’s on a register (not a share one!) is the pump and dump king, or fiddler. also telling people to buy at 2p+.

oh dear. jonathan milner lauded as a genius (he is very savvy obvs) and now he’s a sugar daddy who’s not selling at a large loss as he thinks this is ****ed but to mitigate gains. haha, okay.

laters and phevs, leave those kids alone.

LOTM I’m au fait with going concern old chap, remember last year when you lot didn’t think a raise was needed? We’re going round in circles but mirriad has a £4m loss guided for this year so if they finally manage to hit revenue target and only lose £4m do you really think the auditor will want them to go into next year with £800k and for that to last 6 months to June 30th 2026 or whatever the 2025 audit sign off date is.

Have a good weekend and well done on a good week. See if it lasts. A massive Twitter ramp IMO

Bullish they have less cash than the same tome last year (£6.1m last year and £4.8m this) and they had costs of £2.25m in in Q4 just gone although this year they will reduce it to £2m costs each Q. Mirriad doesn’t have visibility on revenues. They will need cash for audit sign off. They worked on the last raise in April and they will surely work on this one a little earlier as less cash and don’t want to get pants pulled down too badly and leave it too late. Before the 1.25p raise the year before it was 3p.

Saying he can write it off against huge Abcam gains is quite different to oh no it’s the following year so he’ll have a chunky loss he’ll have to carry over. Anyway, Jonathan will have the CEO’ and BoD’s ears so if he’s selling at a large loss he’s not seeing any gains any time soon. Just my view and one that is surely obvious.

You numpty Abcam was bought out in 2023 so this loss is the following tax year. You’re so disingenuous.

If he thought he’d get his money back or even make

Some he would hold. He clearly thinks it’s going lower so it getting back what he can.

Phevs putting a positive spin on it, funny as. I remember when Milner took part in the placing it was amazing (to be fair it was a positive sign) according to Phevs and now he’s sold for a massive loss it’s positive. Deary me.

I knew Jonathan donkeys ago. A very smart guy. I was surprised he bought in at 1.25p placing but now getting what cash he can before the raise.

Jonathan Milner dumping. LinkedIn nonsense or regulated RNSs. Pump and dump.

I suspect meetings were arranged at JOMorgan oncology conference last week so an updated deck.

Before or after April doesn’t matter as Avacta is a Dec YE. They will also post a loss on the sale anyway.

If P1b data is really compelling there is no reason FDA won’t look to approve subject to a P3 being run in tandem. They can approve in or even before P2. I assume that’s why Avacta have gone for orphans, especially SGC which has no standard of care. Quickest way to generate cash.

If DX means they are able to have the accounts signed off in April without a raise I agree with paying in shares. I suspect if they sell DX for say £20m and they say with X cash in bank they are able to continue to Q2 2026 I suspect the share price will recover. They'll hopefully announce P1b started and what the cohort plans are, many patients screened and ready so recruitment not an issue and sentiment can change quickly. Share price recovers and then conversions will mean less of a drag as fewer shares needed and before we know it emerging P1b data is superb and things will really move. If P1b as good we many hope with naive and dox sensitive tumours I am sure there will then be genuine TO moves.

Given revenue is only £1m any campaigns expected to generate 10% of that is deemed material and has to be subject to an RNS. They need a few of them this Q as acknowledged in the last RNS.

Brecause the campaigns are not material and are worth peanuts which is why revenues are dropping and only £1m FY so 1/3rd above just one month's costs.

No I’m long in AVCT. Avct is sadly still at the discounted raise price of 50p and like MIRI they will have to strengthen their balance sheet before audit sign off. I am confident shareholder value will be improved there as opposed to here.

Miri sits at less than 20% of the 1.25p awful raise price so I’m not sure why the creep is bringing that up. Mates rates and sitting at 20% of it, what a tool.

Will the creep dump for a third time?

Bentley I was saying a raise was highly likely in March and April last year due to accounts being signed off and Phevs believed I was talking rubbish and deramping. They then raised at a 40% discount and Phevs accused the co of underhand practises giving the shares away too cheaply. The creep # it as mates rates. Embarrassing and he posted such nonsense on LinkedIn accusing the broker too. Clown.

Phevs the pump and dump creep. I know you’re not the brightest but I suspect you are not a professional investor so will not have access most of the providers who offer such tools. You can arrange a call with a provider which who will ask many questions to see if you tick their boxes so can have access to their services and platform. My only issue was I closed it too early.

Anyway, who cares. Let’s talk about your record of pumping and then selling your shares or shall we keep the what’s going on now. The co has said they need to generate revenue ASAP and the reason is a cash call. Surely that’s obvious.

A reminder from last year - Shareholders should be aware that if the Fundraising does not complete by 30 June 2024, the Company's annual report and accounts will not be signed off by the Company's auditors on a going concern basis.

The Firm Placing is not conditional on the Conditional Placing, the Retail Offer, the Directors' Subscription or the passing of the Resolutions at the General Meeting. As such, the Firm Placing will not be affected by any or all of the above failing to complete for any reason.

Shareholders should be aware that the Resolutions must be passed by Shareholders at the General Meeting in order for the Conditional Placing, the Retail Offer and the Directors' Subscription to proceed. If the Resolutions are not passed, only the net proceeds of the Firm Placing will be received by the Company. In such an event, the Company would need to consider the options available to it in terms of alternative sources of funding. It may be that such sources would not be on terms as favourable to Shareholders as the Fundraising. Further, there is no guarantee that alternative sources could be found. In the event that the Resolutions are not passed and the Fundraising does not complete in full, and if such an alternative source of funding cannot be found, the Company expects that it would only have sufficient cash to fund its activities until the end of August 2024 and it will seek to conduct an orderly wind down of the affairs of the Company substantially before that time.

In the event that the Company is unable to meet such obligations as a result of the failure of the Fundraising to complete in full, and in the event that the Company is unable to secure alternative sources of funding, the Directors believe that it is unlikely that the Company will be able to continue as a going concern and it is highly likely that the Directors would (in order to fulfil their duties to the Company's creditors and to other applicable stakeholders) seek to place the Company into a members voluntary liquidation (which is a solvent liquidation procedure) that will seek to pay all creditors of the Company in full but any such proceeding would be likely to result in little or no value for Shareholders and Shareholders may lose all or a substantial portion of their investment.

These possibilities are considered to be realistic, not remote.

They need to strengthen their balance sheet to have the accounts signed off. That’s surely obvious.